Search companies

Live

Tuesday, 17 November 2026 · 581 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Echo IQ Highlights US Expansion and Regulatory Plans at Healthcare Conference

Echo IQ Limited (EIQ) · Information technology

EIQ: $0.490 +0.00% · MC: $396M

Echo IQ’s conference presentation outlines its US expansion plans for FDA-cleared EchoSolv AS and regulatory strategy for EchoSolv HF, which remains investigational and is not cleared for US commercial distribution. The update follows the company’s recent appointment of former senior FDA official Dr Vasum Peiris as chief medical officer, effective in January.

Source announcements: 2026-11-17 13:38 to 2026-11-17 13:38 Sydney time
Story updated 2026-11-17 13:43 Sydney time
SourcesBell Potter Healthcare Conference Presentation
Comments